Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Aspire Pharma Limited

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Aspire Pharma Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 10

  1. Craig Podolsky 2020-2021 Director View profile
  2. Ian Jacobson 2014-2021 Director View profile
  3. Mark Derek Roberts 2014-2021 Director View profile
  4. Emmanouil Damanakis 2010-2014 Director View profile
  5. Dimitris Kadis 2010-2010 Director View profile
  6. Julie Anne Green 2009-2013 Director View profile
  7. Graham Julian Fraser-Pye 2009-2021 Director View profile
  8. Jane Hill 2009-2011 Director View profile
  9. James Douglas 2009-2009 Director View profile
  10. Debra Joy Roberts 2013-2020 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

Public contracts won

7 contracts · £15,529,352 total

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

  • NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

    NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

    Framework
  • NHS National Generic Pharmaceuticals Interim 2 2020 Buyer: The NHS Commissioning Board (operating under the name of NHS England) Value not published Date not published CPV 33690000 Source: Find a Tender

    Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…

    Framework
  • NP36126 Antibiotic & Genito Urinary Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) Value not published Date not published CPV 33600000 Source: Find a Tender

    Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.

    Framework
  • NHS National Branded Interim - 1 June 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

    Framework
  • NHS National Generics Pharmaceuticals - Supply Chain Resilience Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…

    Framework
  • Generic, Branded Generic & Proprietary Medicinal Products - Group 18 Buyer: Regional Business Services Organisation, Procurement and Logistics Service Value not published Date not published CPV 33600000 Source: Find a Tender

    Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)

  • Generic Drugs – Injections/Infusions 2 Buyer: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Value not published Date not published Source: Find a Tender

    The supply of Generic Drugs – Injections/Infusions 2

About

Incorporated
24/02/2009

Ownership

Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Aspire Pharma Limited is controlled by Aphl 2 Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2019-09-19 · source: Companies House PSC register
  2. Aphl 2 Limited is controlled by Graham Julian Fraser-Pye
    Evidence
    ceased 25-50% shares, 25-50% voting · notified 2018-08-23, ceased 2021-09-03 · source: Companies House PSC register

Ultimately controlled by Graham Julian Fraser-Pye.

10 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Net assets
£87,624,000
Total assets
£89,178,000
Cash
£7,034,000
Employees
1.14
Turnover
Not reported (small or micro-entity accounts)
Profit/loss
£21,824,000

Filed as Full accounts.

Five-year trend

Period endingTurnoverNet assets
2025-12-31Not reported£87,624,000
2025-12-31Not reported£87,624,000

Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

3 directors on the board

5.1y median 6.1y
average tenure
6.1y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (3)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Retail and trade 10Manufacturing 7Finance 6Business services 3

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
06828501
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data